| GU5 Stock | | | EUR 2.12 0.02 0.95% |
Director
Mr. Wu Changhai was serving as Executive Deputy General Manager, Executive Director in GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED since June 28, 2019. He is also Chairman of the Board and General Manager in a pharmaceutical comapny which he served as Deputy General Manager and Acting General Manager, Chairman of the Board in another pharmaceutical comapny, as well as Director in a medicine factory. He used to be Deputy General Manager in a Guangxibased pharmaceutical comapny. He obtained his Bachelor of Engineering from Tongji University, China in July 1989. since 2019.
| Age | 57 |
| Tenure | 5 years |
| Phone | 86 20 6628 1218 |
| Web | https://www.gybys.com.cn |
Guangzhou Baiyunshan Management Efficiency
The company has return on total asset
(ROA) of
0.0356 % which means that it generated a profit of $0.0356 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1281 %, meaning that it generated $0.1281 on every $100 dollars invested by stockholders. Guangzhou Baiyunshan's management efficiency ratios could be used to measure how well Guangzhou Baiyunshan manages its routine affairs as well as how well it operates its assets and liabilities.
Guangzhou Baiyunshan Pharmaceutical has accumulated 752.81
M in total debt with debt to equity ratio
(D/E) of 0.36, which is about average as compared to similar companies. Guangzhou Baiyunshan has a current ratio of 1.61, which is within standard range for the sector. Debt can assist Guangzhou Baiyunshan until it has trouble settling it off, either with new capital or with free cash flow. So, Guangzhou Baiyunshan's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Guangzhou Baiyunshan sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Guangzhou to invest in growth at high rates of return. When we think about Guangzhou Baiyunshan's use of debt, we should always consider it together with cash and equity.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the Peoples Republic of China and internationally. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China. GUANG BAIY operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 25168 people. Guangzhou Baiyunshan Pharmaceutical (GU5) is traded on Frankfurt Exchange in Germany and employs 25,437 people.
Management Performance
Guangzhou Baiyunshan Leadership Team
Elected by the shareholders, the Guangzhou Baiyunshan's board of directors comprises two types of representatives: Guangzhou Baiyunshan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Guangzhou. The board's role is to monitor Guangzhou Baiyunshan's management team and ensure that shareholders' interests are well served. Guangzhou Baiyunshan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Guangzhou Baiyunshan's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiaoping Chu, Independent Director | |
| Changhai Wu, Executive Deputy General Manager, Executive Director | |
| Xuezhen Huang, Secretary of the Board | |
| Zhang Chunbo, Deputy Director | |
| Haiwen Huang, Deputy General Manager | |
| Jun Yang, Executive Director | |
| Weihong Wang, Independent Director | |
| Chunbo Zhang, Deputy General Manager, Executive Director | |
| Juyan Liu, Executive Director | |
| Chuyuan Li, Chairman of the Board, Executive Director | |
| Hong Li, General Manager, Executive Director | |
| Haoshan Zheng, Deputy General Manager | |
| Xianrong Huang, Independent Director | |
| Jianxiong Zheng, Deputy Mang | |
| Ning Cheng, Vice Chairman of the Board, Executive Director | |
| Wenqi Jiang, Independent Director | |
Guangzhou Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Guangzhou Baiyunshan a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Guangzhou Stock
Guangzhou Baiyunshan financial ratios help investors to determine whether Guangzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guangzhou with respect to the benefits of owning Guangzhou Baiyunshan security.